QSS
ACAD icon

Quantitative Systematic Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Quantitative Systematic Strategies’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,281
Closed -$408K – 453
2019
Q2 		$408K Buy
15,281
+6,134
+67% +$157K 0.08% 287
2019
Q1 		$246K Buy
+9,147
New +$214K 0.06% 281
2017
Q2 		– Sell
-6,069
Closed -$209K – 432
2017
Q1 		$209K Buy
+6,069
New +$214K 0.06% 318
2016
Q1 		– Sell
-8,559
Closed -$307K – 404
2015
Q4 		$307K Buy
+8,559
New +$302K 0.08% 411
2015
Q2 		– Sell
-14,843
Closed -$495K – 497
2015
Q1 		$495K Buy
+14,843
New +$510K 0.14% 201

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return